![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
YH Ling, JY Chan, KL Beattie and JA Nelson
Department of Experimental Pediatrics, University of Texas M.D. Anderson Cancer Center, Houston 77030.
The incorporation of 6-thioguanine (S6G) in place of guanine proceeds readily in DNA synthesis reactions catalyzed by mammalian and bacterial polymerases. This report summarizes the consequences of such incorporation studied to date. S6G was incorporated into one strand of a defined M13mp18 phage sequence in a (+)reaction catalyzed by the Klenow fragment of Escherichia coli DNA polymerase I. After denaturation of the newly synthesized strand (containing S6G) and annealing with a reverse (-) 32P-labeled primer, polymerization catalyzed by the Klenow enzyme as well as by human DNA polymerases alpha, gamma, and delta was slowed considerably, compared with that across the corresponding guanine-containing template. To evaluate S6G- containing DNA as a substrate for DNA ligases, two oligodeoxynucleotides (19- and 20-mers) antisense to a 40-mer were synthesized so that the 40-mer coded for guanine at the 3' terminus of the 19-mer. After annealing of the synthetic oligonucleotides to form a duplex DNA containing a one-nucleotide gap (opposite cytosine in the 40- mer), the 19-mer was extended with 2'-deoxythioguanosine 5'- triphosphate using DNA polymerase, forming a nicked duplex DNA. The abilities of T4 DNA ligase and HeLa and calf thymus DNA ligase I to join the 5'-phosphate with the 3'-S6G-OH were severely inhibited, compared with the 3'-guanine-extended control. This finding suggests that incorporation of S6G at the 3' terminus of Okazaki fragments would inhibit lagging strand DNA synthesis. In other experiments, cleavage of S6G-containing DNA by some but not all restriction endonucleases progressed poorly, compared with the control guanine-containing DNA, independently of the location of S6G at recognition or cleavage sites, as previously observed by Iwaniec et al. [Mol. Pharmacol. 39:299-306 (1991)] with a different spectrum of enzymes. These findings indicate altered DNA-protein interactions due to S6G incorporation. The poor template function of S6G-containing DNA is consistent with the known delayed cytotoxicity and DNA damage previously reported to occur in S6G- treated cells.
This article has been cited by other articles:
|
|
 |
|
  S. Hoover and R. Striker Thiopurines inhibit bovine viral diarrhea virus production in a thiopurine methyltransferase-dependent manner J. Gen. Virol., April 1, 2008; 89(4): 1000 - 1009. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Gu and Y. Wang In vitro replication and thermodynamic studies of methylation and oxidation modifications of 6-thioguanine Nucleic Acids Res., June 28, 2007; 35(11): 3693 - 3704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Zaza, M. Cheok, W. Yang, J. C. Panetta, C.-H. Pui, M. V. Relling, and W. E. Evans Gene expression and thioguanine nucleotide disposition in acute lymphoblastic leukemia after in vivo mercaptopurine treatment Blood, September 1, 2005; 106(5): 1778 - 1785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bohon and C. R. de los Santos Effect of 6-thioguanine on the stability of duplex DNA Nucleic Acids Res., May 19, 2005; 33(9): 2880 - 2886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yamane and T. J. Kinsella Casein Kinase 2 Regulates Both Apoptosis and the Cell Cycle Following DNA Damage Induced by 6-Thioguanine Clin. Cancer Res., March 15, 2005; 11(6): 2355 - 2363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. F. Krynetskaia, T. L. Brenner, E. Y. Krynetski, W. Du, J. C. Panetta, P. Ching-Hon, and W. E. Evans Msh2 Deficiency Attenuates But Does Not Abolish Thiopurine Hematopoietic Toxicity in Msh2-/- Mice Mol. Pharmacol., August 1, 2003; 64(2): 456 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bohon and C. R. de los Santos Structural effect of the anticancer agent 6-thioguanine on duplex DNA Nucleic Acids Res., February 15, 2003; 31(4): 1331 - 1338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Somerville, E. Y. Krynetski, N. F. Krynetskaia, R. D. Beger, W. Zhang, C. A. Marhefka, W. E. Evans, and R. W. Kriwacki Structure and Dynamics of Thioguanine-modified Duplex DNA J. Biol. Chem., January 3, 2003; 278(2): 1005 - 1011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. F. KRYNETSKAIA, J. Y. FENG, E. Y. KRYNETSKI, J. V. GARCIA, J. C. PANETTA, K. S. ANDERSON, and W. E. EVANS Deoxythioguanosine triphosphate impairs HIV replication: a new mechanism for an old drug FASEB J, September 1, 2001; 15(11): 1902 - 1908. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Y. Krynetski, N. F. Krynetskaia, A. E. Gallo, K. G. Murti, and W. E. Evans A Novel Protein Complex Distinct from Mismatch Repair Binds Thioguanylated DNA Mol. Pharmacol., February 1, 2001; 59(2): 367 - 374. [Abstract] [Full Text]
|
|
|
|
|
|
N. F. KRYNETSKAIA, X. CAI, J. L. NITISS, E. Y. KRYNETSKI, and M. V. RELLING Thioguanine substitution alters DNA cleavage mediated by topoisomerase II FASEB J, November 1, 2000; 14(14): 2339 - 2344. [Abstract] [Full Text]
|
|
|
|
|
|
S. W. Tendian and W. B. Parker Interaction of Deoxyguanosine Nucleotide Analogs with Human Telomerase Mol. Pharmacol., April 1, 2000; 57(4): 695 - 699. [Abstract] [Full Text]
|
|
|
|
|
|
N. F. Krynetskaia, E. Y. Krynetski, and W. E. Evans Human RNase H-Mediated RNA Cleavage from DNA-RNA Duplexes Is Inhibited by 6-Deoxythioguanosine Incorporation into DNA Mol. Pharmacol., October 1, 1999; 56(4): 841 - 848. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Aubrecht, M. E. P. Goad, and R. H. Schiestl Tissue Specific Toxicities of the Anticancer Drug 6-Thioguanine Is Dependent on the Hprt Status in Transgenic Mice J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 1102 - 1108. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
